D.E. Shaw & Co
NEO icon

D.E. Shaw & Co’s NeoGenomics NEO Stock Holding History

D.E. Shaw & Co’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,000
Closed -$365K – 5616
2022
Q1 		$365K Buy
+30,000
New +$631K ﹤0.01% 4551
2021
Q4 		– Sell
-25,000
Closed -$1.21M – 5596
2021
Q3 		$1.21M Hold
25,000
– – ﹤0.01% 3454
2021
Q2 		$1.13M Buy
+25,000
New +$1.11M ﹤0.01% 3441

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

D.E. Shaw & Co's NEO Position: Q1 2026 in Review

D.E. Shaw & Co reduced its NeoGenomics (NEO) stake by 21% in Q1 2026, selling an estimated $11.9M and leaving 4,164,183 shares worth $30.9M. The position accounts for 0.02% of the portfolio, ranked #907.

D.E. Shaw & Co first reported a position in NEO in Q4 2014 and has held it in 30 quarters since. The position peaked at $62.3M in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • D.E. Shaw & Co held 4,164,183 shares of NeoGenomics worth $30.9M as of Q1 2026.
  • D.E. Shaw & Co sold 1,133,345 NeoGenomics shares in Q1 2026, an estimated $11.9M.
  • NeoGenomics made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #907 holding.
  • D.E. Shaw & Co first reported a position in NeoGenomics in Q4 2014 and has held it in 30 quarters since.
  • D.E. Shaw & Co's NeoGenomics position peaked at $62.3M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.